Verrica Pharmaceuticals Announces Positive Topline Results in Ph

VRCA: Verrica Pharmaceuticals Inc.
2020-11-10 07:30:00
Verrica Pharmaceuticals Announces Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with External Genital Warts (CARE-1)